.jpeg)
What are the side effects of dasatinib? What are the common adverse reactions that patients need to pay attention to when using them?
Dasatinib is a targeted therapy used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). As a tyrosine kinase inhibitor (TKI), dasatinib inhibits the proliferation of leukemia cells by inhibiting BCR-ABL tyrosine kinase activity. Although dasatinib has achieved significant clinical therapeutic effects, its use may still cause certain side effects. The following are common side effects and adverse reactions that patients need to pay special attention to when using dasatinib.
1. Hematological adverse reactions
One of the most common side effects of dasatinib is hematologic adverse reactions, including anemia, leukopenia, and thrombocytopenia. Due to the suppressive effect of dasatinib on bone marrow, patients may experience low white blood cells, low platelets, or anemia. These symptoms may include susceptibility to infection, bleeding, weakness, fatigue, etc. Patients should undergo regular blood routine examinations, especially in the early stages of treatment, so that these hematological abnormalities can be detected promptly and corresponding measures can be taken.
2. Cardiovascular system side effects
Dasatinib may cause abnormal liver function, manifested as elevated aminotransferases (AST/ALT), jaundice, etc. Abnormal liver function is one of the common side effects of targeted therapy drugs. Patients should regularly monitor liver function indicators, especially during the initial period of medication. If symptoms such as loss of appetite, nausea, vomiting, right upper quadrant discomfort, or jaundice occur, patients should seek medical attention immediately to prevent worsening of liver damage. For patients with hepatic impairment, dasatinib should be used with caution and dose adjustment or alternative treatment options may need to be considered.
4. Adverse reactions in the digestive system
The digestive system side effects of dasatinib are also relatively common and may manifest as nausea, vomiting, diarrhea, abdominal pain, etc. Although most of these symptoms are mild or moderate, they may still affect the patient's quality of daily life. In some cases, patients may need to adjust their diet or take antiemetic medications to relieve discomfort. Severe digestive reactions may lead to dehydration or electrolyte imbalance, so patients should maintain adequate fluid intake and adjust medications if necessary.
5. Pulmonary side effects
Dasatinib may also cause adverse pulmonary reactions, such as pulmonary edema, shortness of breath, or cough. Although these side effects are rare, they may affect a patient's respiratory function and cause acute respiratory distress syndrome (ARDS). If patients develop symptoms such as persistent coughing, difficulty breathing, or bloody sputum while taking dasatinib, they should stop taking the medication immediately and seek medical examination. Pulmonary side effects may be life-threatening if not treated promptly.
6. Other adverse reactions
In addition to the common adverse reactions mentioned above, dasatinib may also cause other side effects, such as headache, fatigue, joint pain, rash, hair loss, etc. These symptoms are usually mild or moderate and sometimes gradually lessen as treatment continues. Patients can take some measures during treatment, such as adjusting their daily routine, supplementing nutrition, etc., to alleviate these uncomfortable symptoms.
7. Precautions
When using dasatinib, patients should follow the doctor's advice and conduct regular blood tests, electrocardiograms and liver function monitoring to ensure timely detection of side effects and take appropriate measures. In addition, dasatinib may interact with other drugs, so patients should inform their doctor of all medications they are taking, including prescription drugs, over-the-counter drugs, and herbal supplements, while taking dasatinib. Dasatinib should be used with special caution if the patient has a history of liver, heart, or lung disease.
In summary, although dasatinib is an effective anti-cancer drug, its use may still cause some serious side effects. Therefore, patients need to regularly monitor their health status during treatment, communicate with their doctors in a timely manner, ensure safe medication use, and take early intervention measures when adverse reactions occur.
Reference: https://go.drugbank.com/drugs/DB01254
1. Hematological adverse reactions
One of the most common side effects of dasatinib is hematologic adverse reactions, including anemia, leukopenia, and thrombocytopenia. Due to the suppressive effect of dasatinib on bone marrow, patients may experience low white blood cells, low platelets, or anemia. These symptoms may include susceptibility to infection, bleeding, weakness, fatigue, etc. Patients should undergo regular blood routine examinations, especially in the early stages of treatment, so that these hematological abnormalities can be detected promptly and corresponding measures can be taken.
2. Cardiovascular system side effects
Dasatinib may also affect the cardiovascular system, with the most common side effects including heart failure, chest pain, and irregular heartbeat. Cardiovascular adverse effects are often severe, especially in patients with a history of heart disease. Studies have shown that dasatinib may prolong the QT interval, thereby increasing the risk of serious arrhythmias. Patients should regularly monitor their electrocardiogram (ECG) during medication, and if symptoms such as chest pain and palpitations occur, they should report to their doctor immediately for further examination and treatment.
Dasatinib may cause abnormal liver function, manifested as elevated aminotransferases (AST/ALT), jaundice, etc. Abnormal liver function is one of the common side effects of targeted therapy drugs. Patients should regularly monitor liver function indicators, especially during the initial period of medication. If symptoms such as loss of appetite, nausea, vomiting, right upper quadrant discomfort, or jaundice occur, patients should seek medical attention immediately to prevent worsening of liver damage. For patients with hepatic impairment, dasatinib should be used with caution and dose adjustment or alternative treatment options may need to be considered.
4. Adverse reactions in the digestive system
The digestive system side effects of dasatinib are also relatively common and may manifest as nausea, vomiting, diarrhea, abdominal pain, etc. Although most of these symptoms are mild or moderate, they may still affect the patient's quality of daily life. In some cases, patients may need to adjust their diet or take antiemetic medications to relieve discomfort. Severe digestive reactions may lead to dehydration or electrolyte imbalance, so patients should maintain adequate fluid intake and adjust medications if necessary.
5. Pulmonary side effects
Dasatinib may also cause adverse pulmonary reactions, such as pulmonary edema, shortness of breath, or cough. Although these side effects are rare, they may affect a patient's respiratory function and cause acute respiratory distress syndrome (ARDS). If patients develop symptoms such as persistent coughing, difficulty breathing, or bloody sputum while taking dasatinib, they should stop taking the medication immediately and seek medical examination. Pulmonary side effects may be life-threatening if not treated promptly.
6. Other adverse reactions
In addition to the common adverse reactions mentioned above, dasatinib may also cause other side effects, such as headache, fatigue, joint pain, rash, hair loss, etc. These symptoms are usually mild or moderate and sometimes gradually lessen as treatment continues. Patients can take some measures during treatment, such as adjusting their daily routine, supplementing nutrition, etc., to alleviate these uncomfortable symptoms.
7. Precautions
When using dasatinib, patients should follow the doctor's advice and conduct regular blood tests, electrocardiograms and liver function monitoring to ensure timely detection of side effects and take appropriate measures. In addition, dasatinib may interact with other drugs, so patients should inform their doctor of all medications they are taking, including prescription drugs, over-the-counter drugs, and herbal supplements, while taking dasatinib. Dasatinib should be used with special caution if the patient has a history of liver, heart, or lung disease.
In summary, although dasatinib is an effective anti-cancer drug, its use may still cause some serious side effects. Therefore, patients need to regularly monitor their health status during treatment, communicate with their doctors in a timely manner, ensure safe medication use, and take early intervention measures when adverse reactions occur.
Reference: https://go.drugbank.com/drugs/DB01254
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
